Iovance Biotherapeutics
Dan Kirby is an accomplished executive with extensive experience in the biotechnology and pharmaceutical sectors, serving as Chief Commercial Officer at Iovance Biotherapeutics, Inc., Orca Bio, and Omeros Corporation. Prior roles include Vice President and Head of US Commercial CAR T at Celgene and Vice President overseeing Marketing and Market Access at Juno Therapeutics, Inc. Dan Kirby's leadership in commercial strategy and expertise in market access have been pivotal in driving growth and innovation within these organizations.
This person is not in any teams
This person is not in any offices
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.